Evaluation of Effectiveness and Safety of Everolimus Eluting Stent System (XIENCE V) in the Treatment of Coronary Artery Lesions

KARAKULAK U. N., KAYA E. B., ŞAHİNER M. L., ÖZER N., YORGUN H., Oto A., ...More

EUROPEAN JOURNAL OF THERAPEUTICS, vol.27, no.2, pp.149-157, 2021 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.5152/eurjther.2021.20128
  • Journal Name: EUROPEAN JOURNAL OF THERAPEUTICS
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.149-157
  • Keywords: Drug eluting stent, everolimus, coronary artery disease, ANTIPLATELET THERAPY, CLINICAL-EVALUATION, FOLLOW-UP, OUTCOMES, DISEASE, HYPERTENSION, PREVALENCE, AWARENESS, APPROVAL, TURKEY
  • Hacettepe University Affiliated: Yes

Abstract

Objective: Drug eluting stents have become an important component in percutaneous treatment of patients with symptomatic coronary artery disease. The population in the previous drug eluting stent studies has very risk profile, and therefore not reflects real-world information. Moreover, there are limited data to evaluate risk factors and predictors of intended outcomes. In this study, everolimus eluting stent (XIENCE V) implantations and follow-up results in patients with coronary artery disease were evaluated.